One Historic Week for Flu: Generic Xofluza Approved June 17, mRNA Flu Vaccine VRBPAC Vote June 18 — Here's What Both Mean for 2026–27
3 Articles
3 Articles
One Historic Week for Flu: Generic Xofluza Approved June 17, mRNA Flu Vaccine VRBPAC Vote June 18 — Here's What Both Mean for 2026–27
FDA approved generic baloxavir June 17; VRBPAC voted on mRNA flu vaccine June 18. The 2025–26 flu season killed 24,000 Americans. Here's what both mean for 2026–27.
The Food and Drug Administration is valuing this new injection of Moderna, which is called mFlusive, directed Americans who are adults. For its part, the U.S. biotechnology company and which is a pioneer in messenger RNA drugs (MRNA), seeks total approval for this new vaccine for people between 50 and 64 years of age, “along with authorization for its use in those who are 65 years of age or older while performing additional tests,” describes The…

Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium



